84. サルコイドーシス Sarcoidosis Clinical trials / Disease details
臨床試験数 : 149 / 薬物数 : 202 - (DrugBank : 78) / 標的遺伝子数 : 66 - 標的パスウェイ数 : 169
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00731757 (ClinicalTrials.gov) | May 2009 | 6/8/2008 | Efficacy Study of Humira in the Treatment of Cutaneous Sarcoidosis | A Phase II, Multi-Center, Open Label Study to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous Sarcoidosis | Sarcoidosis;Cutaneous Sarcoidosis | Drug: Humira | Wright State University | Stanford University | Withdrawn | 18 Years | N/A | All | 0 | Phase 2 | United States |
| 2 | EUCTR2006-001816-56-DK (EUCTR) | 11/05/2006 | 28/04/2006 | Can PET scan be used to assess disease activity in patients with sarcoidosis during treatment with adalimumab (Humira)? - KOMPLET | Can PET scan be used to assess disease activity in patients with sarcoidosis during treatment with adalimumab (Humira)? - KOMPLET | sarcoidosis | Trade Name: Humira Product Name: Humira | Rigshospitalet | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | 10 | Phase 2 | Denmark |